Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties

Mona Boules, Beth McMahon, Lewis Warrington, Jennifer Stewart, Joshua Jackson, Abdul Fauq, Daniel J Mc Cormick, Elliott Richelson

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Neurotensin (NT) is a tridecapeptide neurotransmitter in the central nervous system. It has been implicated in the therapeutic effects of neuroleptics. Central activity of NT can only be demonstrated by direct injection into the brain, since it is readily degraded by peptidases in the periphery. We have developed many NT(8-13) analogs that are resistant to peptidase degradation and can cross the blood-brain barrier (BBB). In this study, we report on one of these analogs, NT77L. NT77L induced hypothermia (ED50=6.5 mg/kg, i.p.) but induced analgesia only at the highest dose examined (20 mg/kg, i.p.). Like the atypical neuroleptic clozapine, NT77L blocked the climbing behavior in rats induced by the dopamine agonist apomorphine (600 μg/kg) with an ED50 of 5.6 mg/kg (i.p.), without affecting the licking and the sniffing behaviors. By itself NT77L did not cause catalepsy, but it moderately reversed haloperidol-induced catalepsy with an ED50 of 6.0 mg/kg (i.p.). Haloperidol alone did not lower body temperature, but it potentiated the body temperature lowering effect of NT77L. In studies using in vivo microdialysis NT77L showed similar effects on dopamine turnover to those of clozapine, and significantly different from those of haloperidol in the striatum. In the prefrontal cortex, NT77L significantly increased serotonergic transmission as evidenced by increased 5-hydroxyindole acetic acid:5-hydroxytryptamine (5-HIAA:5-HT) ratio. Thus, NT77L selectively caused hypothermia, over antinociception, while exhibiting atypical neuroleptic-like effects.

Original languageEnglish (US)
Pages (from-to)1-11
Number of pages11
JournalBrain Research
Volume919
Issue number1
DOIs
StatePublished - Nov 16 2001

Fingerprint

Neurotensin
Haloperidol
Hypothermia
Antipsychotic Agents
Catalepsy
Clozapine
neurotensin (8-13)
Body Temperature
Serotonin
Peptide Hydrolases
Induced Hypothermia
Hydroxyindoleacetic Acid
Apomorphine
Dopamine Agonists
Microdialysis
Therapeutic Uses
Prefrontal Cortex
Blood-Brain Barrier
Acetic Acid
Analgesia

Keywords

  • Atypical neuroleptic
  • Catalepsy
  • Microdialysis
  • Neurotensin receptor
  • Subtype

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Boules, M., McMahon, B., Warrington, L., Stewart, J., Jackson, J., Fauq, A., ... Richelson, E. (2001). Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties. Brain Research, 919(1), 1-11. https://doi.org/10.1016/S0006-8993(01)02981-X

Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties. / Boules, Mona; McMahon, Beth; Warrington, Lewis; Stewart, Jennifer; Jackson, Joshua; Fauq, Abdul; Mc Cormick, Daniel J; Richelson, Elliott.

In: Brain Research, Vol. 919, No. 1, 16.11.2001, p. 1-11.

Research output: Contribution to journalArticle

Boules, Mona ; McMahon, Beth ; Warrington, Lewis ; Stewart, Jennifer ; Jackson, Joshua ; Fauq, Abdul ; Mc Cormick, Daniel J ; Richelson, Elliott. / Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties. In: Brain Research. 2001 ; Vol. 919, No. 1. pp. 1-11.
@article{304e9cb022dd4fad80978440a5ec7b7b,
title = "Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties",
abstract = "Neurotensin (NT) is a tridecapeptide neurotransmitter in the central nervous system. It has been implicated in the therapeutic effects of neuroleptics. Central activity of NT can only be demonstrated by direct injection into the brain, since it is readily degraded by peptidases in the periphery. We have developed many NT(8-13) analogs that are resistant to peptidase degradation and can cross the blood-brain barrier (BBB). In this study, we report on one of these analogs, NT77L. NT77L induced hypothermia (ED50=6.5 mg/kg, i.p.) but induced analgesia only at the highest dose examined (20 mg/kg, i.p.). Like the atypical neuroleptic clozapine, NT77L blocked the climbing behavior in rats induced by the dopamine agonist apomorphine (600 μg/kg) with an ED50 of 5.6 mg/kg (i.p.), without affecting the licking and the sniffing behaviors. By itself NT77L did not cause catalepsy, but it moderately reversed haloperidol-induced catalepsy with an ED50 of 6.0 mg/kg (i.p.). Haloperidol alone did not lower body temperature, but it potentiated the body temperature lowering effect of NT77L. In studies using in vivo microdialysis NT77L showed similar effects on dopamine turnover to those of clozapine, and significantly different from those of haloperidol in the striatum. In the prefrontal cortex, NT77L significantly increased serotonergic transmission as evidenced by increased 5-hydroxyindole acetic acid:5-hydroxytryptamine (5-HIAA:5-HT) ratio. Thus, NT77L selectively caused hypothermia, over antinociception, while exhibiting atypical neuroleptic-like effects.",
keywords = "Atypical neuroleptic, Catalepsy, Microdialysis, Neurotensin receptor, Subtype",
author = "Mona Boules and Beth McMahon and Lewis Warrington and Jennifer Stewart and Joshua Jackson and Abdul Fauq and {Mc Cormick}, {Daniel J} and Elliott Richelson",
year = "2001",
month = "11",
day = "16",
doi = "10.1016/S0006-8993(01)02981-X",
language = "English (US)",
volume = "919",
pages = "1--11",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties

AU - Boules, Mona

AU - McMahon, Beth

AU - Warrington, Lewis

AU - Stewart, Jennifer

AU - Jackson, Joshua

AU - Fauq, Abdul

AU - Mc Cormick, Daniel J

AU - Richelson, Elliott

PY - 2001/11/16

Y1 - 2001/11/16

N2 - Neurotensin (NT) is a tridecapeptide neurotransmitter in the central nervous system. It has been implicated in the therapeutic effects of neuroleptics. Central activity of NT can only be demonstrated by direct injection into the brain, since it is readily degraded by peptidases in the periphery. We have developed many NT(8-13) analogs that are resistant to peptidase degradation and can cross the blood-brain barrier (BBB). In this study, we report on one of these analogs, NT77L. NT77L induced hypothermia (ED50=6.5 mg/kg, i.p.) but induced analgesia only at the highest dose examined (20 mg/kg, i.p.). Like the atypical neuroleptic clozapine, NT77L blocked the climbing behavior in rats induced by the dopamine agonist apomorphine (600 μg/kg) with an ED50 of 5.6 mg/kg (i.p.), without affecting the licking and the sniffing behaviors. By itself NT77L did not cause catalepsy, but it moderately reversed haloperidol-induced catalepsy with an ED50 of 6.0 mg/kg (i.p.). Haloperidol alone did not lower body temperature, but it potentiated the body temperature lowering effect of NT77L. In studies using in vivo microdialysis NT77L showed similar effects on dopamine turnover to those of clozapine, and significantly different from those of haloperidol in the striatum. In the prefrontal cortex, NT77L significantly increased serotonergic transmission as evidenced by increased 5-hydroxyindole acetic acid:5-hydroxytryptamine (5-HIAA:5-HT) ratio. Thus, NT77L selectively caused hypothermia, over antinociception, while exhibiting atypical neuroleptic-like effects.

AB - Neurotensin (NT) is a tridecapeptide neurotransmitter in the central nervous system. It has been implicated in the therapeutic effects of neuroleptics. Central activity of NT can only be demonstrated by direct injection into the brain, since it is readily degraded by peptidases in the periphery. We have developed many NT(8-13) analogs that are resistant to peptidase degradation and can cross the blood-brain barrier (BBB). In this study, we report on one of these analogs, NT77L. NT77L induced hypothermia (ED50=6.5 mg/kg, i.p.) but induced analgesia only at the highest dose examined (20 mg/kg, i.p.). Like the atypical neuroleptic clozapine, NT77L blocked the climbing behavior in rats induced by the dopamine agonist apomorphine (600 μg/kg) with an ED50 of 5.6 mg/kg (i.p.), without affecting the licking and the sniffing behaviors. By itself NT77L did not cause catalepsy, but it moderately reversed haloperidol-induced catalepsy with an ED50 of 6.0 mg/kg (i.p.). Haloperidol alone did not lower body temperature, but it potentiated the body temperature lowering effect of NT77L. In studies using in vivo microdialysis NT77L showed similar effects on dopamine turnover to those of clozapine, and significantly different from those of haloperidol in the striatum. In the prefrontal cortex, NT77L significantly increased serotonergic transmission as evidenced by increased 5-hydroxyindole acetic acid:5-hydroxytryptamine (5-HIAA:5-HT) ratio. Thus, NT77L selectively caused hypothermia, over antinociception, while exhibiting atypical neuroleptic-like effects.

KW - Atypical neuroleptic

KW - Catalepsy

KW - Microdialysis

KW - Neurotensin receptor

KW - Subtype

UR - http://www.scopus.com/inward/record.url?scp=0035900186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035900186&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(01)02981-X

DO - 10.1016/S0006-8993(01)02981-X

M3 - Article

C2 - 11689157

AN - SCOPUS:0035900186

VL - 919

SP - 1

EP - 11

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -